Biovie (BIVI) Common Equity (2013 - 2026)
Biovie (BIVI) recorded Common Equity of $10.27 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 46.0% from $19.01 million a year earlier and down 34.2% from the prior quarter.
Powered by 
Analysis
Biovie (BIVI) Common Equity (2013 - 2026) Analysis & Trends
Starting with fiscal Q4 2013, Biovie's Common Equity history includes 52 quarters.
- Annual Common Equity has a five-year compound annual growth rate of 15.3% (FY2021 to FY2026).
- Across earlier fiscal years, Common Equity came in at $19.01 million in FY2025 (+22.6%), $15.51 million in FY2024 (+1.1%), $15.34 million in FY2023 (+317.9%) and $3.67 million in FY2022 (-27.3%).
- The fiscal Q4 2026 figure is the lowest quarterly Common Equity since fiscal Q2 2024.
- On a year-over-year basis, Common Equity has declined for three consecutive quarters, with growth averaging 40.9% over the last eight quarters.
- Peak year-over-year performance for Common Equity in the last five years was growth of 317.9% in fiscal Q4 2023, against a decline of 71.3% in fiscal Q2 2024 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $15.61 million (Q3 2026), $19.27 million (Q2 2026) and $24.92 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Biovie | 11.62 Mn | 11.62 Mn | - | 10.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.27 Mn |
| Mar 31, 2026 | 15.61 Mn |
| Dec 31, 2025 | 19.27 Mn |
| Sep 30, 2025 | 24.92 Mn |
| Jun 30, 2025 | 19.01 Mn |
| Mar 31, 2025 | 21.82 Mn |
| Dec 31, 2024 | 23.92 Mn |
| Sep 30, 2024 | 14.07 Mn |
| Jun 30, 2024 | 15.51 Mn |
| Mar 31, 2024 | 18.93 Mn |
| Dec 31, 2023 | 7.49 Mn |
| Sep 30, 2023 | 7.55 Mn |
| Jun 30, 2023 | 15.34 Mn |
| Mar 31, 2023 | 21.72 Mn |
| Dec 31, 2022 | 26.07 Mn |
| Sep 30, 2022 | 5.96 Mn |
| Jun 30, 2022 | 3.67 Mn |
| Mar 31, 2022 | 9.95 Mn |
| Dec 31, 2021 | 16.07 Mn |
| Sep 30, 2021 | 20.23 Mn |
API Access
Biovie Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=BIVI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "BIVI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=BIVI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();